TY - JOUR
T1 - Quantitative analysis of methylglyoxal, glyoxal and free advanced glycation end-products in the plasma of wistar rats during the oral glucose tolerance test
AU - Chen, Si Jing
AU - Aikawa, Chiwa
AU - Matsui, Toshiro
N1 - Publisher Copyright:
© 2015 The Pharmaceutical Society of Japan.
PY - 2015/2/1
Y1 - 2015/2/1
N2 - The purpose of this study was to gain insight into the production behavior of free adducts of advanced glycation end-products (AGEs) in Wistar rats under acute hyperglycemic conditions. Five AGE-free adducts as well as their precursors (i.e., highly reactive carbonyl intermediates of methylglyoxal and glyoxal) in rat plasma were quantitatively determined at greater than nanomolar levels using the liquid chromatography/ tandem mass spectrometry method coupled with 2,4,6-trinitrobenzene sulfonate and 2,3-diaminonaphthalene derivatization techniques. An oral glucose (2 g/kg dose) tolerance test to 10-week-old Wistar rats provided evidence that the plasma levels of diabetes-related metabolites did not change acutely within 120 min, irrespective of increasing blood glucose levels.
AB - The purpose of this study was to gain insight into the production behavior of free adducts of advanced glycation end-products (AGEs) in Wistar rats under acute hyperglycemic conditions. Five AGE-free adducts as well as their precursors (i.e., highly reactive carbonyl intermediates of methylglyoxal and glyoxal) in rat plasma were quantitatively determined at greater than nanomolar levels using the liquid chromatography/ tandem mass spectrometry method coupled with 2,4,6-trinitrobenzene sulfonate and 2,3-diaminonaphthalene derivatization techniques. An oral glucose (2 g/kg dose) tolerance test to 10-week-old Wistar rats provided evidence that the plasma levels of diabetes-related metabolites did not change acutely within 120 min, irrespective of increasing blood glucose levels.
UR - http://www.scopus.com/inward/record.url?scp=84964253609&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84964253609&partnerID=8YFLogxK
U2 - 10.1248/bpb.b14-00698
DO - 10.1248/bpb.b14-00698
M3 - Article
C2 - 25747995
AN - SCOPUS:84964253609
SN - 0918-6158
VL - 38
SP - 336
EP - 339
JO - Biological and Pharmaceutical Bulletin
JF - Biological and Pharmaceutical Bulletin
IS - 2
ER -